Literature DB >> 29204750

Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.

Ryoko Watanabe1, Takumi Kurose1, Yuta Morishige2,3, Ko Fujimori4.   

Abstract

6-Hydroxydopamine (6-OHDA) induces the production of reactive oxygen species (ROS) that are associated with various neurodegenerative diseases such as Parkinson's disease. 3,3',4',7-Tetrahydroxyflavone (fisetin), a plant flavonoid has a variety of physiological effects such as antioxidant activity. In this study, we investigated the molecular mechanism of the neuroprotective effects of fisetin against 6-OHDA-induced cell death in human neuroblastoma SH-SY5Y cells. 6-OHDA-mediated cell toxicity was reduced in a fisetin concentration-dependent manner. 6-OHDA-mediated elevation of the expression of the oxidative stress-related genes such as hemeoxygenase-1, NAD(P)H dehydrogenase quinone 1, NF-E2-related factor 2, and γ-glutamate-cysteine ligase modifier was suppressed by fisetin. Fisetin also lowered the ratio of the proapoptotic Bax protein and the antiapoptotic Bcl-2 protein in SH-SY5Y cells. Moreover, fisetin effectively suppressed 6-OHDA-mediated activation of caspase-3 and caspase-9, which leads to the cell death, while, 6-OHDA-induced caspase-3/7 activity was lowered. Furthermore, fisetin activated the PI3K-Akt signaling, which inhibits the caspase cascade, and fisetin-mediated inhibition of 6-OHDA-induced cell death was negated by the co-treatment with an Akt inhibitor. These results indicate that fisetin protects 6-OHDA-induced cell death by activating PI3K-Akt signaling in human neuronal SH-SY5Y cells. This is the first report that the PI3K-Akt signaling is involved in the fisetin-protected ROS-mediated neuronal cell death.

Entities:  

Keywords:  6-OHDA; Caspase; Fisetin; PI3K-Akt; SH-SY5Y cells

Mesh:

Substances:

Year:  2017        PMID: 29204750     DOI: 10.1007/s11064-017-2445-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

Review 1.  Pharmacological treatment of Parkinson disease: a review.

Authors:  Barbara S Connolly; Anthony E Lang
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

2.  Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and Diffuse Lewy body disease.

Authors:  A Tortosa; E López; I Ferrer
Journal:  Neurosci Lett       Date:  1997-11-28       Impact factor: 3.046

3.  Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.

Authors:  Naghma Khan; Farrukh Afaq; Fatima H Khusro; Vaqar Mustafa Adhami; Yewseok Suh; Hasan Mukhtar
Journal:  Int J Cancer       Date:  2011-08-26       Impact factor: 7.396

4.  Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory.

Authors:  Pamela Maher; Tatsuhiro Akaishi; Kazuho Abe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

Review 5.  Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Authors:  G Di Carlo; N Mascolo; A A Izzo; F Capasso
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 6.  Flavonoids: a review of probable mechanisms of action and potential applications.

Authors:  R J Nijveldt; E van Nood; D E van Hoorn; P G Boelens; K van Norren; P A van Leeuwen
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

7.  Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling.

Authors:  Marie Will; Alice Can Ran Qin; Weiyi Toy; Zhan Yao; Vanessa Rodrik-Outmezguine; Claudia Schneider; Xiaodong Huang; Prashant Monian; Xuejun Jiang; Elisa de Stanchina; José Baselga; Ningshu Liu; Sarat Chandarlapaty; Neal Rosen
Journal:  Cancer Discov       Date:  2014-01-16       Impact factor: 39.397

8.  Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain.

Authors:  Dharmalingam Prakash; Ganapasam Sudhandiran
Journal:  J Nutr Biochem       Date:  2015-08-08       Impact factor: 6.048

9.  The neuroprotective effect of fisetin in the MPTP model of Parkinson's disease.

Authors:  Mital Y Patel; Hirenkumar V Panchal; Othman Ghribi; Kenza E Benzeroual
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

Review 10.  Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids.

Authors:  Mohammed Kawser Hossain; Ahmed Abdal Dayem; Jihae Han; Yingfu Yin; Kyeongseok Kim; Subbroto Kumar Saha; Gwang-Mo Yang; Hye Yeon Choi; Ssang-Goo Cho
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

View more
  4 in total

1.  Small Molecule Fisetin Modulates Alpha-Synuclein Aggregation.

Authors:  Rita Rosado-Ramos; Joana Godinho-Pereira; Daniela Marques; Inês Figueira; Tiago Fleming Outeiro; Regina Menezes; Cláudia Nunes Dos Santos
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

Review 2.  Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.

Authors:  Marianna Tosato; Valerio Di Marco
Journal:  Biomolecules       Date:  2019-07-09

3.  Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling.

Authors:  Hai-Feng Zhang; Hai-Bo Zhang; Xue-Ping Wu; Ya-Ling Guo; Wei-Dong Cheng; Feng Qian
Journal:  Acta Pharmacol Sin       Date:  2020-07-13       Impact factor: 6.150

4.  Fisetin Prevents HT22 Cells From High Glucose-Induced Neurotoxicity via PI3K/Akt/CREB Signaling Pathway.

Authors:  Shenshen Zhang; Ran Xue; Yaping Geng; Hao Wang; Wenjie Li
Journal:  Front Neurosci       Date:  2020-03-19       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.